Douglas Shlonsky
About Douglas Shlonsky
Douglas Shlonsky is a Senior Professional Sales Representative at Supernus Pharmaceuticals, Inc., where he has worked since 2014. He specializes in promoting epilepsy products and has a background in Political Science from the University of Kentucky.
Work at Supernus Pharmaceuticals
Douglas Shlonsky has been employed at Supernus Pharmaceuticals, Inc. as a Senior Professional Sales Representative since 2014. He operates out of Lexington, Kentucky, where he focuses on promoting the company's products for the treatment of central nervous system diseases. His role involves engaging with healthcare professionals to increase awareness and adoption of Supernus Pharmaceuticals' offerings.
Previous Experience at Sprint
Before joining Supernus Pharmaceuticals, Douglas Shlonsky worked at Sprint as a Business Account Executive. His tenure lasted from 2013 to 2014, during which he was based in Louisville, Kentucky. In this position, he was responsible for managing business accounts and fostering client relationships.
Education and Expertise
Douglas Shlonsky earned a Bachelor of Arts (B.A.) degree in Political Science and Government from the University of Kentucky. He attended the university from 2009 to 2013, completing his studies in four years. His educational background provides a foundation for his analytical skills and understanding of market dynamics in the pharmaceutical industry.
Achievements in Sales Performance
In 2016, Douglas Shlonsky achieved notable success in his sales role by securing 1st place in Oxtellar XR market share growth nationwide. He ranked 1st out of 179 representatives, demonstrating his effectiveness in promoting the product and contributing to the company's overall success in the epilepsy market.
Focus on Central Nervous System Diseases
Douglas Shlonsky's professional focus is on building future successes in the treatment of central nervous system diseases. His work at Supernus Pharmaceuticals involves advocating for innovative treatments that address the needs of patients with conditions such as epilepsy.